ZP5-9676
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZP5-9676, covering 2025-09-25 to 2025-09-25. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH) [Phase 3]